NuVasive®, Inc.
A
A

NEWS

April 28, 2016

NuVasive Extends Spine Innovator Leadership Position, Launches New Solutions At 84th AANS Annual Scientific Meeting

New Technologies Designed to Deliver Superior and Reproducible Outcomes

SAN DIEGO, CA – April [28], 2016 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced it will …


April 26, 2016

NuVasive Reports First Quarter 2016 Financial Results

Company Delivers Double-Digit Revenue Growth of 11.8% and
Profitability Expansion of 150 Basis Points

SAN DIEGO, CA – April 26, 2016 – NuVasive, Inc. (Nasdaq: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated …


April 6, 2016

Nuvasive Announces Conference Call and Webcast of First Quarter 2016 Results

SAN DIEGO, CA – April 6, 2016 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that its first quarter 2016 earnings announcement will take place on …


April 4, 2016

Nuvasive Launches Integrated Global Alignment (iGA™) Platform At Britspine 2016

LONDON, England – April 4, 2016 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that it will participate in BritSpine 2016 held April 6-8, 2016 at …


March 11, 2016

NuVasive, Inc. Announces Pricing Of Offering Of $550 Million Of 2.25% Convertible Senior Notes Due 2021

SAN DIEGO, CA – March 11, 2016 — NuVasive, Inc. (NASDAQ: NUVA) announced today the pricing of its offering of $550,000,000 aggregate principal amount of 2.25% Convertible Senior Notes due 2021 (the “Convertible Notes”) in a private placement to qualified …


March 9, 2016

Nuvasive, Inc. Announces Proposed Offering Of $550 Million Of Convertible Senior Notes Due 2021

SAN DIEGO, CA, March 9, 2016 — NuVasive, Inc. (NASDAQ: NUVA) announced today that it intends to offer, subject to market and other considerations, $550,000,000 aggregate principal amount of Convertible Senior Notes due 2021 (the “Convertible Notes”) in a private …


March 9, 2016

NuVasive Announces Regulatory Approval Of Reline® Posterior Fixation Technology In Japan

Largest and Fastest Growing International Market Readies for Introduction of iGA™ Platform to Address Spinal Alignment and Drive Improved Long-Term Patient Outcomes

SAN DIEGO, CA – March 9, 2016 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused …


March 7, 2016

NuVasive Announces Agreement To Acquire Brazilian Distributor Mega Surgical

SAN DIEGO, CA – March 7, 2016 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that it has entered into a definitive agreement to acquire Mega …


February 11, 2016

NuVasive Elects Robert F. Friel And Donald J. Rosenberg To Board Of Directors

SAN DIEGO, CA – February 11, 2016 – The Board of Directors of NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointment of Robert F. Friel …


February 11, 2016

NuVasive Reports Fourth Quarter And Full Year 2015 Financial Results

Company Drives Record High Revenue of $811.1 Million and
Delivers Record Profitability Expansion of 400 Basis Points for the Full Year 2015

 

 Completes Acquisition of Ellipse Technologies, Inc. and Provides
Updated 2016 Financial Performance Guidance

SAN DIEGO, CA –


January 26, 2016

NuVasive Announces Conference Call and Webcast of Fourth Quarter 2015 Results

SAN DIEGO, CA – January 26, 2016 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that its fourth quarter and full year 2015 earnings announcement will …


January 12, 2016

NuVasive Announces Select Preliminary Full-Year 2015 Financial Results And Reiterates 2016 Outlook

  • Preliminary full year 2015 revenue of approximately $811 million; reflects 6% growth versus prior year, or 8% on a constant currency basis
  • Preliminary full year 2015 non-GAAP operating profit margin anticipated to exceed guidance of 15.2%
  • Reiterates full year 2016

January 7, 2016

NuVasive To Participate In Investor Event In January 2016

SAN DIEGO, CA – January 7, 2016 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will participate in the following investor event in January …


January 5, 2016

NuVasive To Acquire Ellipse Technologies

Reflects NuVasive’s Focus on Transformative Spine Solutions, Reinforces Leadership Position with the Addition of Fast-Growing Complex Deformity Franchise

Expected to Accelerate the Company’s Revenue Growth and be Accretive to
Non-GAAP Diluted Earnings Per Share within First 12 Months

Investor Conference


December 10, 2015

NuVasive Announces Location For New State-Of-The-Art Manufacturing Facility

SAN DIEGO, CA – December 10, 2015NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that the Company has selected a site in West Carrollton, Ohio …


December 10, 2015

NuVasive Hosts 2015 Investor Day

Company Provides Updated Long-Term Financial Performance Goals,
Reiterates 2015 Guidance and Issues Preliminary 2016 Financial Performance Expectations

SAN DIEGO, CA – December 10, 2015 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with …


December 1, 2015

NuVasive Appoints Jason D. Hanson As Executive Vice President, Strategy, Corporate Development And General Counsel

SAN DIEGO, CA – December 1, 2015 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that Jason D. Hanson is joining the Company as Executive Vice …


October 27, 2015

NuVasive Reports Third Quarter 2015 Financial Results

Third Quarter 2015 Highlights:

  • Revenue increased 5.6% to $200.5 million, or 7.8% on a constant currency basis;
  • Non-GAAP operating profit margin increased 460 basis points to 16.3%; GAAP operating profit margin of 14.0%; 
  • Adjusted EBITDA margin increased 540 basis points

October 13, 2015

NuVasive To Showcase Integrated Global Alignment Platform at North American Spine Society 30th Annual Meeting

SAN DIEGO, CA – October 13, 2015 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive and procedurally integrated solutions, today announced that it will attend the North American Spine Society …


October 12, 2015

NuVasive Receives First Ever FDA 510(k) Clearance of Cervical Corpectomy Cage

SAN DIEGO, CA – October 12, 2015 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today the first ever FDA 510(k) clearance of a cervical corpectomy cage. …


October 8, 2015

NuVasive Announces Conference Call And Webcast Of Third Quarter 2015 Results

SAN DIEGO, CA – October 8, 2015 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that its third quarter 2015 earnings announcement will take place on …


September 30, 2015

NuVasive Spine Foundation Exceeds $18 Million In Global Effort To Support Spine Surgery Patients In Need

The NSF’s Record Fundraising to Provide Life-Changing Spine Surgeries to
Disadvantaged Global Communities

SAN DIEGO, CA – September 30, 2015 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, …


September 2, 2015

NuVasive® To Participate In Investor Events In September 2015

NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will participate in the following investor events in September 2015:

September 1, 2015

NuVasive® To Launch Integrated Global Alignment Platform For Select International Markets At Eurospine 2015

Company to present technical exhibit and host workshop focused on
achieving more precise spinal column alignment

SAN DIEGO, CA – September 1, 2015 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally …


August 25, 2015

NuVasive® To Significantly Expand Manufacturing

NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that it intends to expand its manufacturing capabilities to meet growing demand for NuVasive’s innovative spine technology and is actively exploring locations to build-out a new state-of-the-art medical device facility for its spinal implant and instrument manufacturing.

August 18, 2015

NuVasive® Appoints Johnson Lai Chief Information Officer

SAN DIEGO, CA – August 18, 2015 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that Johnson Lai has been appointed Chief Information Officer, effective August …


August 10, 2015

NuVasive® To Participate In Upcoming Investor Event

SAN DIEGO, CA – August 10, 2015 – NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive or the “Company”), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will participate in the following …


July 28, 2015

NuVasive® Reports Second Quarter 2015 Financial Results

Second Quarter 2015 Highlights:

  • Revenue increased 6.4% to $202.9 million, or 8.5% on a constant currency basis;
  • Non-GAAP operating profit margin of 15.3%; GAAP operating profit margin of 12.7%; 
  • Adjusted EBITDA margin of 24.9%;
  • Non-GAAP net income of $15.7 million;

July 28, 2015

NuVasive® Announces Definitive Settlement With United States

SAN DIEGO, CA – July 28, 2015 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that it has reached a definitive settlement with the U.S. Department …


July 16, 2015

NuVasive® Taps Veteran Company Leader Jason M. Hannon To Accelerate International Expansion Efforts

AMSTERDAM, the Netherlands – July 16, 2015 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that Jason M. Hannon has been appointed Executive Vice President, International …


July 13, 2015

NuVasive CEO Announces New Executive Leadership Team

SAN DIEGO, CA – July 13, 2015 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced new executive appointments to create a world-class leadership team to drive …


July 6, 2015

NuVasive Elects Daniel J. Wolterman To Its Board Of Directors

NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that Daniel J. Wolterman has been elected to the Company’s Board of Directors. It is expected that Mr. Wolterman will also serve on the Board’s Compensation Committee.

July 1, 2015

NuVasive Announces Conference Call And Webcast Of Second Quarter 2015 Results

NuVasive, Inc, a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that its second quarter 2015 earnings announcement will take place on Tuesday, July 28, 2015 after the close of the market.

June 16, 2015

NuVasive Elects Vickie L. Capps To Its Board Of Directors

NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that Vickie L. Capps has been elected to the Company’s Board of Directors.

May 28, 2015

NuVasive To Participate In Investor Events In June 2015

NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive or the “Company”), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will participate in the following investor events in June 2015:

May 26, 2015

NuVasive Appoints Gregory T. Lucier Chief Executive Officer

NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive” or the “Company”), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that Gregory T. Lucier has been appointed Chief Executive Officer, effective immediately.

May 7, 2015

NuVasive® To Participate In Investor Events In May 2015

SAN DIEGO, CA – May 7, 2015 – NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive or the “Company”), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will participate in the …


May 4, 2015

NuVasive® Reports First Quarter 2015 Financial Results

NuVasive, Inc. (Nasdaq: NUVA) (“NuVasive” or the “Company”), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today financial results for the quarter ended March 31, 2015.

May 4, 2015

NuVasive® Launches Integrated Global Alignment (iGA™) Platform At AANS 2015

Company Introduces First of Its Kind Technology for Intraoperative Reconciliation to Ensure Optimal Alignment in Spine Surgery

SAN DIEGO, CA – May 4, 2015 – NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive or the “Company”), a leading medical device company focused on


April 29, 2015

NuVasive® Reaches Agreement In Principle To Settle OIG Matter

SAN DIEGO, CA – April 29, 2015 — NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive” or the “Company”), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, today announced that it has reached an agreement …


April 27, 2015

NuVasive® To Launch Game-Changing Surgical Platform At The American Association Of Neurological Surgeons 83rd Annual Meeting

SAN DIEGO, CA – April 27, 2015 – NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive or the “Company”), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its participation at the 83rd


April 8, 2015

NuVasive® Announces Conference Call and Webcast of First Quarter 2015 Results

SAN DIEGO, CA – April 8, 2015 – NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive” or the “Company”), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that its first quarter 2015 earnings …


April 1, 2015

NuVasive® Announces Leadership Transition

  • Gregory T. Lucier Appointed Chairman and Interim Chief Executive Officer
  • Alex V. Lukianov Steps Down as Chairman and Chief Executive Officer
  • Company Anticipates 2015 First Quarter Revenue Will Exceed $190 Million, Including More Than $2 Million of Currency Headwinds

SAN


March 3, 2015

NuVasive® Announces Successful Appeal of Medtronic Verdict

SAN DIEGO, CA – March 3, 2015 – NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive” or the “Company”), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, today announced that the Court of Appeals for …


February 26, 2015

NuVasive® To Participate In Investor Events In March 2015

SAN DIEGO, CA – February 26, 2015 – NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive” or the “Company”), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that management will participate in the …


February 24, 2015

NuVasive Announces Updated Non-GAAP Definition

SAN DIEGO, CA – February 24, 2015 – NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive” or the “Company”), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, today announced that it will implement an updated …


February 24, 2015

NuVasive Reports Fourth Quarter and Full Year 2014 Financial Results

Company Provides 2015 Financial Performance Guidance Reflective of

Updated Non-GAAP Definition

Fourth Quarter 2014 Highlights:

  • Revenue increased 7.1% to $204.3 million;
  • Non-GAAP operating profit margin of 20.3%; GAAP operating profit margin of 12.0%; 
  • Non-GAAP net income of $20.0 million, or

February 4, 2015

NuVasive® To Participate In Investor Event In February 2015

NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive” or the “Company”), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that management will participate in the following investor event in February 2015:

January 12, 2015

NuVasive® Announces Select Preliminary Unaudited Full-Year 2014 Financial Results and 2015 Outlook

  • Preliminary full-year 2014 revenue of approximately $761 million; reflects 11% growth over the prior year, or 12% on a constant currency basis
  • Preliminary full-year 2014 non-GAAP operating margin anticipated to exceed guidance of 16.5%
  • Full-year 2015 revenue of approximately $810

January 12, 2015

NuVasive® Announces Expanded Leadership Roles for Executives Pat Miles and Matt Link

  • Pat Miles Named President and Chief Operating Officer
  • Matt Link Named President, U.S. Sales and Services
  • Keith Valentine to Step Down as Chief Operating Officer

SAN DIEGO, CA – January 12, 2015 – NuVasive, Inc. (NASDAQ: NUVA), a medical device …


January 5, 2015

NuVasive® to Participate in Investor Events in January 2015

SAN DIEGO, CA – January 5, 2015 – NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that management will participate in the following investor event in …


November 25, 2014

NuVasive® to Participate in Investor Events in December 2014

SAN DIEGO, CA – November 24, 2014 – NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that management will participate in the following investor events in …


November 10, 2014

NuVasive® Focused on Surgeon Support and Showcasing Industry-Leading Products at North American Spine Society 29th Annual Meeting

SAN DIEGO, CA – November 10, 2014 – NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive or the “Company”), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, today announced that it will attend the 29…


November 3, 2014

NuVasive® To Host Investor Morning on November 13, 2014

SAN DIEGO, CA – November 3, 2014 – NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive” or the “Company”), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that it will host a meeting …


October 30, 2014

NuVasive® Reports Third Quarter 2014 Financial Results and Increases Full Year Guidance

  • Third quarter total revenue increased 12.3% to $189.9 million;
  • Non-GAAP operating profit margin of 16.7%; GAAP operating margin of 8.6%;  
  • Non-GAAP earnings of $9.6 million, or $0.19 per share; GAAP net loss of $(1.8) million, or $(0.04) per share;

October 22, 2014

NuVasive® Announces Conference Call and Webcast of Third Quarter 2014 Results

SAN DIEGO, CA – October 16, 2014 – NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that its third quarter 2014 earnings announcement will take place …


October 1, 2014

NuVasive® Demonstrates Expanding EMEA Business at Eurospine 2014 with Surgeon Workshops and Innovative Product Exhibition

  • Product demonstrations and spine procedure workshops highlight commitment to serving the needs of patients and surgeons in Europe
  • Company also announces opening of new European Center of Excellence in Amsterdam

SAN DIEGO, CA – October 01, 2014 – NuVasive, Inc. …


September 8, 2014

NuVasive Spine Foundation™ Exceeds $13 Million in Global Effort to Support Patients in Need

The NSF raises more than $13 million to provide life-changing spine surgeries to disadvantaged global communities

SAN DIEGO, CA – September 8, 2014 – NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and …


August 25, 2014

NuVasive® to Participate in Investor Events in August and September 2014

SAN DIEGO, CA — (Marketwired) — 08/05/14 — NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that management will participate in the following investor events in …


July 29, 2014

NuVasive Reports Second Quarter 2014 Financial Results and Increases Full Year Guidance

SAN DIEGO, CA–(Marketwired – July 29, 2014) –

  • Second quarter total revenue increased 15.1% to $190.7 million, moving NuVasive into the #3 spot in the global spine market;
  • Non-GAAP operating profit margin of 16.0%; GAAP operating margin of 2.4%;
  • Non-GAAP

July 16, 2014

NuVasive® Announces Conference Call And Webcast of Second Quarter 2014 Results

SAN DIEGO, July 15, 2014 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that its second quarter 2014 earnings announcement will take place on Tuesday, …


July 9, 2014

NuVasive® to Participate in the 21st Annual International Meeting on Advanced Spine Techniques (IMAST)

SAN DIEGO, July 9, 2014NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to announce its participation at the 21st International Meeting on …


July 7, 2014

NuVasive® Names Carol Cox Executive Vice President Strategy and Corporate Communications

SAN DIEGO, July 7, 2014NuVasive, Inc. (Nasdaq: NUVA), announced today that Carol Cox has joined the company as executive vice president of Strategy and Corporate Communications effective immediately. She will report directly to Alex Lukianov, Chairman and …


June 23, 2014

NuVasive® Announces the Release of the Next Generation Monitoring Platform for Spine Surgery

SAN DIEGO, June 23, 2014NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to announce the release of a next generation monitoring platform with …


May 8, 2014

NuVasive® to Ring NASDAQ Opening Bell

SAN DIEGO, CA — (Marketwired) — 05/08/14 — NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that it will celebrate ten years as a publicly


May 7, 2014

NuVasive® Management to Participate in Investor Events in May and June 2014

SAN DIEGO, CA — (Marketwired) — 05/07/14 — NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that management will participate in the following investor events in …


May 6, 2014

NuVasive® Announces Favorable Resolution of Patent Lawsuit Against Cadwell Laboratories, Inc.

SAN DIEGO, CA — (Marketwired) — 05/06/14 — NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that it reached a settlement agreement with Cadwell Laboratories,


May 1, 2014

NuVasive® Solutions Recognized for Advancing Spine Technology and Patient Care

SAN DIEGO, CA–(Marketwired – May 01, 2014) – NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is pleased to announce that the XLIF® Anterior Column Realignment …


April 29, 2014

NuVasive® Reports First Quarter 2014 Financial Results

SAN DIEGO, CA–(Marketwired – April 29, 2014) – NuVasive, Inc. (NASDAQ: NUVA)

  • First quarter 2014 total revenue of $177.5 million; up 11.3% from first quarter 2013;
  • $30 million litigation liability recognized due to a recent jury verdict, which remains

April 29, 2014

NuVasive® Announces Executive Leadership Transition

SAN DIEGO, CA–(Marketwired – April 29, 2014) – NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that Michael Lambert intends to retire from his role …


April 15, 2014

NuVasive® Announces Conference Call And Webcast of First Quarter 2014 Results

SAN DIEGO, CA–(Marketwired – April 15, 2014) – NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that its first quarter 2014 earnings announcement will take …


April 14, 2014

NuVasive® Japan Office Marks One-Year Anniversary of Outstanding Customer and Patient Support

SAN DIEGO, April 14, 2014NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced that today marks the one-year anniversary since it opened its NuVasive Japan office …


March 21, 2014

Local Medical Device Company, NuVasive®, Sponsors the 6th Annual San Diego Festival of Science and Engineering Expo Day

 

SAN DIEGO, March 21, 2014 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to sponsor the 6th Annual San Diego Festival of Science …


March 4, 2014

NuVasive® to Exhibit Comprehensive Spine Portfolio at the 30th Annual Meeting of the AANS/CNS Section on Disorders of the Spine and Peripheral Nerves

SAN DIEGO, CA–(Marketwired – March 04, 2014) – NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to announce its participation at the 30th Annual Meeting …


March 4, 2014

NuVasive® Reports Fourth Quarter and Full Year 2013 Financial Results

SAN DIEGO, CA–(Marketwired – March 03, 2014) – NuVasive, Inc. (NASDAQ: NUVA)

  • Fourth quarter 2013 total revenue of $190.8 million; up 15.1% from fourth quarter 2012
  • Full year 2013 total revenue of $685.2 million; up 10.5% from full year

February 19, 2014

NuVasive® Solutions Named on Becker’s ASC Review List of “100 Minimally Invasive Orthopedic & Spine Devices to Know”

SAN DIEGO, February 18, 2014 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is pleased to announce that three of the Company’s innovative products were named on …


February 5, 2014

NuVasive® Announces Strategic Executive Leadership Changes

SAN DIEGO, CA–(Marketwired – February 05, 2014) – NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is pleased to announce executive leadership changes that will foster the …


December 30, 2013

NuVasive® to Present at J.P. Morgan Healthcare Conference

NuVasive to Present at J.P. Morgan Healthcare Conference

SAN DIEGO, December 30, 2013 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that Alex Lukianov, Chairman …


December 20, 2013

NuVasive® Manufacturing, LLC., Expands U.S. Workforce to Drive Speed of Innovation®

SAN DIEGO and DAYTON, December 20, 2013 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that NuVasive Manufacturing, LLC., (NML) will expand its workforce by …


December 19, 2013

NuVasive® Further Strengthens Leadership Team in Europe

SAN DIEGO, December 19, 2013 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to announce the continued expansion of the Company’s Europe, Middle East & …


December 17, 2013

NuVasive® Announces the U.S. Launch of ALIF ACR™

SAN DIEGO, December 17, 2013 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to announce the United States launch of ALIF ACR(Anterior Lumbar …


December 5, 2013

NuVasive® Announces Appointment of Gregory T. Lucier To the NuVasive Board of Directors

SAN DIEGO, December 4, 2013 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that Gregory T. Lucier has been named to the NuVasive Board of …


December 3, 2013

NuVasive® to Participate in the 8th Annual Meeting of the German Spine Society

SAN DIEGO, December 3, 2013 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is pleased to announce the Company’s participation in the 8th Annual Meeting of …


November 26, 2013

NuVasive® Named One of the Fastest Growing Technology Companies in North America on Deloitte’s 2013 Technology Fast 500™

SAN DIEGO, CA–(Marketwired – November 26, 2013) – NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to announce that NuVasive was named one of the …


November 4, 2013

NuVasive® to Host Investor Morning on November 14, 2013

SAN DIEGO, November 4, 2013 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that it will host a meeting for investors and analysts at its …


October 16, 2013

NuVasive® Celebrates a Decade of Changing Spine Surgery at NASS 2013

SAN DIEGO, October 16, 2013 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, featured its game-changing products and procedures and celebrated a decade of changing spine surgery …


October 7, 2013

NuVasive® to Exhibit Game-Changing New Products and Procedures at the 28th Annual North American Spine Society Annual Meeting

SAN DIEGO, October 7, 2013 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that it will exhibit several game-changing new products and procedurally integrated solutions …


October 3, 2013

NuVasive® Announces the U.S. Launch of the XLIF Decade™ Plate

SAN DIEGO, October 3, 2013 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to announce the domestic launch of the XLIF Decade™ Plate.

The XLIF …


October 1, 2013

NuVasive® to Showcase Comprehensive Product Portfolio at EuroSpine 2013

SAN DIEGO, October 1, 2013 – NuVasive, Inc. (Nasdaq: NUVA), NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that it will showcase the Company’s comprehensive spine …


September 26, 2013

NuVasive® Announces First Patients in Japan Treated with Precept® Posterior Fixation System

SAN DIEGO, September 26, 2013 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that the first surgeries were performed in Japan using the Precept®


September 19, 2013

Corporate Directors Forum Names NuVasive® Board Member as Director of the Year

SAN DIEGO, September 19, 2013 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is proud to announce that the Corporate Directors Forum (CDF) named the Company’s long-standing …


September 6, 2013

The NuVasive Spine Foundation™ Expands Global Impact to Support Patients in Need

SAN DIEGO, September 6, 2013 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to announce that the NuVasive Spine Foundation (NSF), a non-profit organization …


August 15, 2013

NuVasive® Announces Expansion and Relocation of UK Office

SAN DIEGO, August 15, 2013 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to announce the expansion and relocation of the Company’s UK office.

The …


July 30, 2013

NuVasive Announces Second Quarter 2013 Financial Results

SAN DIEGO, CA–(Marketwired – July 30, 2013) – NuVasive, Inc. (NASDAQ: NUVA)

  • Second quarter 2013 revenue of $165.7 million; up 7.3% from second quarter 2012
  • Non-GAAP operating margin of 14.0%
  • GAAP net loss of $6.5 million, or $0.15 per

July 16, 2013

NuVasive® Announces Conference Call And Webcast of Second Quarter 2013 Results

SAN DIEGO, July 16, 2013 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced details today relating to its second quarter 2013 earnings announcement, which will take …


July 10, 2013

NuVasive® to Exhibit Innovative Products and Procedures at IMAST 2013

SAN DIEGO, July 10, 2013 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to announce their participation at the 20th International Meeting on Advanced …


June 27, 2013

Basketball Hall-of-Famer Bill Walton Embarks on Patient Seminar Tour with The Better Way Back®

SAN DIEGO, June 27, 2013 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that The Better Way Back®, a NuVasive-supported patient education program,

June 12, 2013

NuVasive® Announces Court Ruling Regarding Ongoing Royalties

SAN DIEGO, CA–(Marketwired – June 12, 2013) – NuVasive, Inc. (NASDAQ: NUVA) a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that it received a ruling from the U.S. District …


May 31, 2013

NuVasive® Announces Global Launch of MAS® PLIF

SAN DIEGO, May 31, 2013 – NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to announce the global launch of its Maximum Access Surgery Posterior Lumbar …


May 6, 2013

NuVasive® Announces Acquisition of Manufacturing Facility

SAN DIEGO, CA–(Marketwired – May 06, 2013) – NuVasive, Inc. (NASDAQ: NUVA)

  • Marks foray into full scale implant manufacturing
  • Creates long term opportunity to improve operating margin

NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing …